Skip to content

Effects of intravenous dexamethasone at different time on low back and leg pain and outcome after lumbar spine surgery

Effects of intravenous dexamethasone at different time on low back and leg pain and outcome after lumbar spine surgery

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800016974
Enrollment
Unknown
Registered
2018-07-05
Start date
2018-07-16
Completion date
Unknown
Last updated
2018-10-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute pain after lumbar surgery

Interventions

D1:0.2 mg/kg dexamethasone was injected intravenously 1 h before surgery, and 0.2 mg/kg saline was intravenously administered immediately after the surgery
D2:0.2 mg/kg saline was injected intravenously 1 h before surgery, and 0.2 mg/kg dexamethasonewas intravenously administered immediately after the surgery
C?:Intravenous injection of the same dose of normal saline at each time point

Sponsors

Department of Anesthesiology, Affiliated Hospital of Xuzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. aged 18-75 years; 2. American Society of Anaesthesiologists (ASA) physical status classification of I-II; 3. Lower extremity radiation pain with or without numbness symptoms lasted for more than 3 months, regular conservative treatment for 8 weeks is invalid; 4. patients who are scheduled for one or two segmental posterior lumbar decompression and bone graft fusion.

Exclusion criteria

Exclusion criteria: 1. diabetic mellitus; 2. pregnancy or lactation; 3. previous lumbar spine surgery; 4. inability to cooperate; 5. had any known allergy or contraindication to dexamethasone; 6. undergone more than three levels of laminectomy; 7. had received chronic steroid or opioids; 8. severe hepatic or renal impairment.

Design outcomes

Primary

MeasureTime frame
Visual analogue pain scale on low back and leg;

Secondary

MeasureTime frame
CRP, IL-6, IL-10 and TNF-a;Oswestry disability index score;Lower limb numbness, fatigue and weakness;Improved Macnab efficacy assessment;Frequecy for compress PICA;the first pressing time of the analgesic pump;Frequecy for analgesic rescue and consumption;Length of hospital stay;Sleep quality;Adverse reaction such as nause and vomiting, postoperative sore throat, hoaseness;

Countries

China

Contacts

Public ContactYanming

Department of Anesthesiology, Affiliated Hospital of Xuzhou Medical University

yjy3001@163.com+86 18052268329

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026